Documents

December 2011

• Senate Judiciary Committee Approves Leahy Bill To Hike Penalties For Counterfeit Drugs
• Generic Drug Industry Urges Congress To Support New User Fee Agreement
• Final Conference Meeting Slated For Dec. 8 On Remaining Approps Bills
• NIOSH Blogs On Respiratory Protection For Handling Engineered Nanoparticles
• FDA Statement Explaining HHS' Decision To Overrule Agency On Plan B
• Advocates In Letter To HHS Encourage Comprehensive Essential Health Benefits Package
• Testimony From Senate Judiciary Panel's Hearing On Express Scripts-Medco Merger
• Dietary Supplement Industry Calls For Overhaul Of FDA's NDI Draft Guidance
• Schumer Introduces Bill To Stem Drug Shortages
• 73 Consumer Groups Urge Congress Not To Undermine MLR Rule
• AARP Launches Print Ad Urging SGR Fix
• FDA Notice Lays Out Proposed Biosimilars User Fee Structure
• Report Finds Reform Law Could Cut Uninsured Rate For Children By Another 40% In 2014
• FDA Changes Risk Strategy Requirements For 2 Drugs To Treat Low Platelet Counts
• AdvaMed Applauds Introduction Of Legislation To Streamline De Novo Classification Process
• Hospitals Discourage Medicare, Medicaid Cuts As SGR Pay-For
• AMA Floats Charts Showing Escalating Costs Of SGR Reform
• Public Citizen's Sid Wolf Protests His Exclusion From FDA Advisory Panel
• Administration Backs House Passage Of PAHPA
• CMS Finishes Regulation Aimed At Allowing Comparisons Of Doctor Performance
• Industry Funded Study Explores Economic Benefits Of PBMs
• GOP Sens Urge Thorough Review Of ESI-Medco Merger
• Dept. Of Labor Releases ACA Proposed Rules Addressing MEWAs And Fraud
• ASSE Highlights Nuclear Safety
• CMS Announces Registration Open For Round 2 DME Bidding